Literature DB >> 24162788

Early lesions of follicular lymphoma: a genetic perspective.

Emilie Mamessier1, Joo Y Song, Franziska C Eberle, Svetlana Pack, Charlotte Drevet, Bruno Chetaille, Ziedulla Abdullaev, José Adelaïde, Daniel Birnbaum, Max Chaffanet, Stefania Pittaluga, Sandrine Roulland, Andreas Chott, Elaine S Jaffe, Bertrand Nadel.   

Abstract

The pathogenesis of follicular lymphoma is a multi-hit process progressing over many years through the accumulation of numerous genetic alterations. Besides the hallmark t(14;18), it is still unclear which other oncogenic hits contribute to the early steps of transformation and in which precursor stages these occur. To address this issue, we performed high-resolution comparative genomic hybridization microarrays on laser-capture micro-dissected cases of follicular lymphoma in situ (n=4), partial involvement by follicular lymphoma (n=4), and duodenal follicular lymphoma (n=4), assumed to represent, potentially, the earliest stages in the evolution of follicular lymphoma. Cases of reactive follicular hyperplasia (n=2), uninvolved areas from follicular lymphoma in situ lymph nodes, follicular lymphoma grade 1-2 (n=5) and follicular lymphoma grade 3A (n=5) were used as controls. Surprisingly, alterations involving several relevant (onco)genes were found in all entities, but at significantly lower proportions than in overt follicular lymphoma. While the number of alterations clearly assigns all these entities as precursors, the pattern of partial involvement by follicular lymphoma alterations was quantitatively and qualitatively closer to that of follicular lymphoma, indicating significant selective pressure in line with its faster rate of progression. Among the most notable alterations, we observed and validated deletions of 1p36 and gains of the 7p and 12q chromosomes and related oncogenes, which include some of the most recurrent oncogenic alterations in overt follicular lymphoma (TNFRSF14, EZH2, MLL2). By further delineating distinctive and hierarchical molecular and genetic features of early follicular lymphoma entities, our analysis underlines the importance of applying appropriate criteria for the differential diagnosis. It also provides a first set of candidates likely to be involved in the cascade of hits that pave the path of the various progression phases to follicular lymphoma development.

Entities:  

Mesh:

Year:  2013        PMID: 24162788      PMCID: PMC3943311          DOI: 10.3324/haematol.2013.094474

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  49 in total

1.  High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes.

Authors:  K-John J Cheung; Allen Delaney; Susana Ben-Neriah; Jacquie Schein; Tang Lee; Sohrab P Shah; Dorothy Cheung; Nathalie A Johnson; Andrew J Mungall; Adele Telenius; Betty Lai; Merrill Boyle; Joseph M Connors; Randy D Gascoyne; Marco A Marra; Douglas E Horsman
Journal:  Genes Chromosomes Cancer       Date:  2010-08       Impact factor: 5.006

Review 2.  RUNX1 translocations and fusion genes in malignant hemopathies.

Authors:  Etienne De Braekeleer; Nathalie Douet-Guilbert; Frédéric Morel; Marie-Josée Le Bris; Claude Férec; Marc De Braekeleer
Journal:  Future Oncol       Date:  2011-01       Impact factor: 3.404

3.  A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.

Authors:  Marina Bousquet; Cyril Broccardo; Cathy Quelen; Fabienne Meggetto; Emilienne Kuhlein; Georges Delsol; Nicole Dastugue; Pierre Brousset
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

4.  Alternate pathways for Bcl6-mediated regulation of B cell to plasma cell differentiation.

Authors:  Jukka Alinikula; Kalle-Pekka Nera; Sini Junttila; Olli Lassila
Journal:  Eur J Immunol       Date:  2011-07-06       Impact factor: 5.532

5.  Does "in situ lymphoma" occur as a distinct step in the development of nodular lymphocyte-predominant Hodgkin lymphoma?

Authors:  Antonino Carbone
Journal:  Cancer       Date:  2011-07-05       Impact factor: 6.860

6.  In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.

Authors:  Peijie Cong; Mark Raffeld; Julie Teruya-Feldstein; Lynn Sorbara; Stefania Pittaluga; Elaine S Jaffe
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

7.  Expression analysis of alpha-NAC and ANX2 in juvenile myelomonocytic leukemia using SMART polymerase chain reaction and "virtual Northern" hybridization.

Authors:  Klaus Hämmerle; Parviz Shayan; Charlotte M Niemeyer; Christian Flotho
Journal:  Cancer Genet Cytogenet       Date:  2003-04-15

8.  Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.

Authors:  Ellen Leich; Itziar Salaverria; Silvia Bea; Andreas Zettl; George Wright; Victor Moreno; Randy D Gascoyne; Wing-Chung Chan; Rita M Braziel; Lisa M Rimsza; Dennis D Weisenburger; Jan Delabie; Elaine S Jaffe; Andrew Lister; Jude Fitzgibbon; Louis M Staudt; Elena M Hartmann; Hans-Konrad Mueller-Hermelink; Elias Campo; German Ott; Andreas Rosenwald
Journal:  Blood       Date:  2009-05-26       Impact factor: 22.113

9.  A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.

Authors:  Satoshi Morishige; Eijiro Oku; Yuka Takata; Yoshizo Kimura; Fumiko Arakawa; Ritsuko Seki; Rie Imamura; Koichi Osaki; Michitoshi Hashiguchi; Kazuaki Yakushiji; Shinichi Mizuno; Koji Yoshimoto; Koji Nagafuji; Koichi Ohshima; Takashi Okamura
Journal:  Acta Haematol       Date:  2012-11-17       Impact factor: 2.195

10.  Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation.

Authors:  Oliver Weigert; Nadja Kopp; Andrew A Lane; Akinori Yoda; Suzanne E Dahlberg; Donna Neuberg; Anita Y Bahar; Bjoern Chapuy; Jeffery L Kutok; Janina A Longtine; Frank C Kuo; Terry Haley; Maura Salois; Timothy J Sullivan; David C Fisher; Edward A Fox; Scott J Rodig; Joseph H Antin; David M Weinstock
Journal:  Cancer Discov       Date:  2011-12-12       Impact factor: 39.397

View more
  19 in total

1.  t(14;18)-positive B cells: is it seed or soil?

Authors:  Elaine S Jaffe; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2018-10-18       Impact factor: 22.113

2.  CREBBP gene mutations are frequently detected in in situ follicular neoplasia.

Authors:  Janine Schmidt; Joan Enric Ramis-Zaldivar; Irina Bonzheim; Julia Steinhilber; Inga Müller; Andrea Haake; Shan Chi Yu; Mark Raffeld; Falko Fend; Itziar Salaverria; Reiner Siebert; Elaine S Jaffe; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

Review 3.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

Review 4.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

Review 5.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 7.  Nature and importance of follicular lymphoma precursors.

Authors:  Emilie Mamessier; Florence Broussais-Guillaumot; Bruno Chetaille; Reda Bouabdallah; Luc Xerri; Elaine S Jaffe; Bertrand Nadel
Journal:  Haematologica       Date:  2014-05       Impact factor: 9.941

8.  Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression.

Authors:  Stéphanie Sungalee; Emilie Mamessier; Ester Morgado; Emilie Grégoire; Philip Z Brohawn; Christopher A Morehouse; Nathalie Jouve; Céline Monvoisin; Cédric Menard; Guilhaume Debroas; Mustapha Faroudi; Violaine Mechin; Jean-Marc Navarro; Charlotte Drevet; Franziska C Eberle; Lionel Chasson; Fannie Baudimont; Stéphane J Mancini; Julie Tellier; Jean-Michel Picquenot; Rachel Kelly; Paolo Vineis; Philippe Ruminy; Bruno Chetaille; Elaine S Jaffe; Claudine Schiff; Jean Hardwigsen; David A Tice; Brandon W Higgs; Karin Tarte; Bertrand Nadel; Sandrine Roulland
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

9.  Clonally related duodenal-type follicular lymphoma and in situ follicular neoplasia.

Authors:  Dominik Nann; Irina Bonzheim; Inga Müller; Barbara Mankel; Leticia Quintanilla-Martínez; Bence Sipos; Falko Fend
Journal:  Haematologica       Date:  2019-08-01       Impact factor: 9.941

10.  Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.

Authors:  Stephen J Salipante; Andrew Adey; Anju Thomas; Choli Lee; Yajuan J Liu; Akash Kumar; Alexandra P Lewis; David Wu; Jonathan R Fromm; Jay Shendure
Journal:  Genes Chromosomes Cancer       Date:  2015-12-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.